These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31625621)

  • 21. Prednisolone and Prednisone Pharmacokinetics in Adult Renal Transplant Recipients.
    Skauby RH; Gustavsen MT; Andersen AM; Bjerre A; Åsberg A; Midtvedt K; Vethe NT; Bergan S
    Ther Drug Monit; 2021 Apr; 43(2):247-255. PubMed ID: 33181621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal women.
    Meno-Tetang GM; Blum RA; Schwartz KE; Jusko WJ
    J Clin Pharmacol; 2001 Nov; 41(11):1195-205. PubMed ID: 11697752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous determination of plasma prednisolone, prednisone, and cortisol levels by high-performance liquid chromatography.
    Majid O; Akhlaghi F; Lee T; Holt DW; Trull A
    Ther Drug Monit; 2001 Apr; 23(2):163-8. PubMed ID: 11294518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Learning pharmacokinetic models for in vivo glucocorticoid activation.
    Bunte K; Smith DJ; Chappell MJ; Hassan-Smith ZK; Tomlinson JW; Arlt W; Tiňo P
    J Theor Biol; 2018 Oct; 455():222-231. PubMed ID: 30048717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone.
    Möllmann H; Hochhaus G; Rohatagi S; Barth J; Derendorf H
    Pharm Res; 1995 Jul; 12(7):1096-100. PubMed ID: 7494809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prednisolone concentrations in cerebrospinal fluid after oral prednisone. Preliminary data.
    Bannwarth B; Schaeverbeke T; Péhourcq F; Vernhes JP; D'Yvoire MB; Dehais J
    Rev Rhum Engl Ed; 1997 May; 64(5):301-4. PubMed ID: 9190003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of rofecoxib on prednisolone and prednisone pharmacokinetics in healthy subjects.
    Schwartz JI; Mukhopadhyay S; Porras AG; Viswanathan-Aiyer KJ; Adcock S; Ebel DL; Gertz BJ
    J Clin Pharmacol; 2003 Feb; 43(2):187-92. PubMed ID: 12616672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The non-linear pharmacokinetics of prednisone and prednisolone. III. Experiments using the rabbit as an animal model.
    Ferry JJ; Wagner JG
    Biopharm Drug Dispos; 1988; 9(4):363-76. PubMed ID: 3207856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.
    Huang ML; Jusko WJ
    J Pharmacokinet Biopharm; 1990 Oct; 18(5):401-21. PubMed ID: 2266496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics of prednisone and prednisolone.
    Frey BM; Frey FJ
    Clin Pharmacokinet; 1990 Aug; 19(2):126-46. PubMed ID: 2199128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability and reversible metabolism of prednisone and prednisolone in man.
    Garg V; Jusko WJ
    Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glucocorticoids: mode of action and pharmacokinetics].
    Emilie D; Etienne S
    Rev Prat; 1990 Feb; 40(6):511-7. PubMed ID: 2320875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prednisolone and Prednisone Pharmacokinetics in Pediatric Renal Transplant Recipients-A Prospective Study.
    Skauby RH; Bjerre A; Sæves I; Vethe NT; Bremer S; Svarstad A; Bergan S
    Ther Drug Monit; 2017 Oct; 39(5):472-482. PubMed ID: 28749817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the anti-inflammatory agent tenidap on the pharmacokinetics and pharmacodynamics of prednisolone.
    Garg V; Blum R; Wilner KD; Jusko WJ
    J Clin Pharmacol; 1992 Mar; 32(3):222-30. PubMed ID: 1564126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A practical limited sampling strategy to predict free prednisolone exposure and glycemia in kidney transplant recipients.
    Yates CJ; Barraclough KA; McWhinney BC; Ungerer JP; Fullinfaw RO; Colman PG; Fourlanos S; Cohney SJ
    Ther Drug Monit; 2014 Feb; 36(1):18-23. PubMed ID: 24335760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetic parameters of prednisone and prednisolone in healthy volunteers].
    Etienne SD; Vandermeersch V; Chosidow O; Vu-Thi-My-Le C; Godeau P; Diquet B; Herson S
    Ann Med Interne (Paris); 1990; 141(6):507-11. PubMed ID: 2285202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prednisolone: limited sampling strategies for estimating pharmacokinetic parameters.
    Suarez-Kurtz G; Estrela Rde C; Salvadori MC
    Ther Drug Monit; 2004 Feb; 26(1):16-22. PubMed ID: 14749544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of prednisone and prednisolone in a case of hypothyroidism: effect of replacement therapy.
    Bergamaschi S; Rusconi R; Gervasoni M; Rigamonti AE; Cella S; Bareggi SR
    Steroids; 2005 Oct; 70(11):787-9. PubMed ID: 16045952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients.
    Chosidow O; Etienne SD; Diquet B; Vandermeersch V; Vu-Thi-My-Le C; Herson S; Puech AJ
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):376-80. PubMed ID: 1938000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP.
    Baudry E; Huguet S; Couderc AL; Chaibi P; Bret F; Verny C; Weill S; Madar O; Urien S; Rezai K
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):775-785. PubMed ID: 30689002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.